Effects of antipsychotic medications on quality of life and psychosocial functioning in patients with early-stage schizophrenia: 1-year follow-up naturalistic study

Comprehensive Psychiatry

Volumn 53, Issue 7, 2012, Pages 1006-1012

  Guo, Xiaofeng ^a   Zhang, Zhanchou ^a   Zhai, Jinguo ^b   Fang, Maosheng ^c   Hu, Maorong ^a   Wu, Renrong ^a   Liu, Zhening ^a   Zhao, Jingping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b JINING MEDICAL UNIVERSITY   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SULPIRIDE;

ADULT; ARTICLE; DAILY LIFE ACTIVITY; FEMALE; FOLLOW UP; GLOBAL ASSESSMENT SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; QUALITY OF LIFE; RATING SCALE; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SHORT FORM 36; SOCIAL PSYCHOLOGY; TREATMENT DURATION;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL ADJUSTMENT; TREATMENT OUTCOME;

EID: 84866487775     PISSN: 0010440X     EISSN: 15328384     Source Type: Journal    
DOI: 10.1016/j.comppsych.2012.03.003     Document Type: Article

References (39)

1. J.M. Narvaez, E.W. Twamley, C.L. McKibbin, R.K. Heaton, and T.L. Patterson Subjective and objective quality of life in schizophrenia Schizophr Res 98 1-3 2008 201 208
2. H. Herrman, G. Hawthorne, and R. Thomas Quality of life assessment in people living with psychosis Soc Psychiatry Psychiatr Epidemiol 37 2002 510 518
3. The World Health Organization Quality of Life Assessment WHOQOL) Development and general psychometric properties Soc Sci Med 46 12 1998 1569 1585
4. A. Hofer, G. Kemmler, U. Eder, M. Edlinger, M. Hummer, and W.W. Fleischhacker Quality of life in schizophrenia: The impact of psychopathology, attitude toward medication, and side effects J Clin Psychiatry 65 7 2004 932 939
5. M. Ritsner, I. Modai, J. Endicott, O. Rivkin, Y. Nechamkin, and P. Barak Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients J Clin Psychiatry 61 2000 880 889
6. J. Caron, C. Mercier, P. Diaz, and A. Martin Socio-demographic and clinical predictors of quality of life in patients with schizophrenia or schizo-affective disorder Psychiatry Res 137 3 2005 203 213
7. A. Karow, and D. Naber Subjective well-being and quality of life under atypical antipsychotic treatment Psychopharmacology 162 2002 3 10
8. M. Lambert, B.G. Schimmelmann, D. Naber, A. Schacht, A. Karow, and T. Wagner Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia J Clin Psychiatry 67 11 2006 1690 1697
9. S. Leucht, C. Corves, D. Arbter, R.R. Engel, C. Li, and J.M. Davis Second- generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis Lancet 373 9657 2009 31 41
10. J.A. Lieberman, T.S. Stroup, J.P. McEvoy, M.S. Swartz, R.A. Rosenheck, and D.O. Perkins Effectiveness of antipsychotic drugs in patients with chronic schizophrenia N Engl J Med 353 2005 1209 1223
11. P.M. Wehmeier, M. Kluge, E. Schneider, A. Schacht, T. Wagner, and W. Schreiber Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 31 3 2007 703 712
12. R. Kilian, and M.C. Angermeyer The effects of antipsychotic treatment on quality of life of schizophrenic patients under naturalistic treatment conditions: An application of random effect regression models and propensity scores in an observational prospective trial Qual Life Res 14 5 2005 1275 1289
13. M.S. Swartz, D.O. Perkins, T.S. Stroup, S.M. Davis, G. Capuano, and R.A. Rosenheck Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: Findings from the NIMH CATIE study Am J Psychiatry 164 3 2007 428 436
14. J.E. Ware, M. Kosinski, and S.D. Keller SF-36 Physical and Mental Health Summary Scales: A User's Manual 1994 The Health Institute Boston, MA
15. J.E. Ware, and C.D. Sherborne The MOS 36-item short-form Health Status Survey (SF-36): I. Conceptual framework and item selection Med Care 30 1992 473 483
16. C.J. Meijer, A.H. Schene, and M.W. Koeter Quality of life in schizophrenia measured by the MOS SF-36 and lancashire quality of life profile: A comparison Acta Psychiatr Scand 105 2002 293 300
17. S. Priebe Social outcomes in schizophrenia Br J Psychiatry 191(Suppl) 2007 15 20
18. D.A. Revicki, L.A. Genduso, S.H. Hamilton, D. Ganoczy, and C.M. Beasley Jr Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: Quality of life and clinical outcomes of a randomized clinical trial Qual Life Res 8 5 1999 417 426
19. S.M. Strakowski, J.L. Johnson, M.P. Delbello, R.M. Hamer, A.I. Green, and M. Tohen Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode Schizophr Res 78 2-3 2005 161 169
20. T.M. Si, L. Shu, X. Yu, C. Ma, G.H. Wang, and P.S. Bai Antipsychotic drug patterns of schizophrenia in china: A cross-sectioned study Chin J Psychiatry 37 3 2004 152 155 [in Chinese]
21. X. Guo, M. Fang, J. Zhai, B. Wang, C. Wang, and B. Hu Effectiveness of maintenance treatments with atypical and typical antipsychotics in stable schizophrenia with early stage: 1-year naturalistic study Psychopharmacology (Berl) 216 4 2011 475 484
22. X.F. Guo, J.G. Zhai, Z.N. Liu, M.S. Fang, B. Wang, and C.Y. Wang Effect of antipsychotic medication alone vs combined with psychosocial intervention on outcomes of early-stage schizophrenia: A randomized, 1-year study Arch Gen Psychiatry 67 9 2010 895 904
23. S.R. Kay, A. Fiszbein, and L.A. Opler The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr Bull 13 2 1987 261 276
24. J. Kane, G. Honigfeld, J. Singer, and H. Meltzer Clozapine for treatment-resistant schizophrenia Arch Gen Psychiatry 45 1988 789 796
25. W. Guy ECDEU Assessment Manual for Psychopharmacology, Revised 1976 US Department of Health, Education, and Welfare Rockville, MD 583 585
26. S. Katz, A.B. Ford, R.W. Moskowitz, B.A. Jackson, and M.W. Jaffe Studies of illness in the aged: The index of ADL: a standardized measure of biological and psychosocial function JAMA 185 12 1963 914 919
27. S.A. Montgomery, and M. Asberg A new depression scale designed to be sensitive to change Br J Psychiatry 134 1979 382 389
28. G.M. Simpson, and J.W.S. Angus A rating scale for extrapyramidal side effects Acta Psychiatr Scand 212 Suppl 1970 11 19
29. D.C. Howell Statistical methods for psychology (7th Ed.) 2009 Wadsworth, Cengage Learning Australia
30. D. Naber, M. Riedel, A. Klimke, E.U. Vorbach, M. Lambert, and K.U. Kühn Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia Acta Psychiatr Scand 111 2005 106 115
31. M. Ritsner, A. Gibel, G. Perelroyzen, R. Kurs, M. Jabarin, and Y. Ratner Quality of life outcomes of risperidone, olanzapine, and typical antipsychotics among schizophrenia patients treated in routine clinical practice: A naturalistic comparative study J Clin Psychopharmacol 24 2004 582 591
32. R. Kilian, S. Dietrich, M. Toumi, and M.C. Angermeyer Quality of life in persons with schizophrenia in out-patient treatment with first- or second-generation antipsychotics Acta Psychiatr Scand 110 2004 108 118
33. C.W. Law, E.Y. Chen, E.F. Cheung, R.C. Chan, J.G. Wong, and C.L. Lam Impact of untreated psychosis on quality of life in patients with first-episode schizophrenia Qual Life Res 14 2005 1803 1811
34. S. Wegener, M.A. Redoblado-Hodge, S. Lucas, D. Fitzgerald, A. Harris, and J. Brennan Relative contributions of psychiatric symptoms and neuropsychological functioning to quality of life in first-episode psychosis Aust N Z J Psychiatr 39 2005 487 492
35. Y.T. Xiang, C.Y. Wang, Y. Wang, H.F. Chiu, J.P. Zhao, and Q. Chen Socio-demographic and clinical determinants of quality of life in Chinese patients with schizophrenia: A prospective study Qual Life Res 19 3 2010 317 322
36. S. Browne, M. Roe, A. Lane, M. Gervin, M. Morris, and A. Kinsella Quality of life in schizophrenia: Relationship to sociodemographic factors, symptomatology and tardive dyskinesia Acta Psychiatr Scand 94 1996 118 124
37. P.W. Corrigan, and B. Buican The construct validity of subjective quality of life for the severely mentally ill J Nerv Ment Dis 183 1995 281 285
38. S.M. Eack, and C.E. Newhill Psychiatric symptoms and quality of life in schizophrenia: A Meta-Analysis Schizophr Bull 33 5 2007 1225 1237
39. Y.T. Xiang, Y.Z. Weng, C.M. Leung, W.K. Tang, and G.S. Ungvari Quality of life of Chinese schizophrenia outpatients in Hong Kong: Relationship to sociodemographic factors and symptomatology Aust N Z J Psychiatr 41 2007 442 449